Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bernal-Bello

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
The Lancet. Respiratory Medicine|June 20, 2021
Imatinib in COVID-19: hope and cautionDavid Bernal-Bello, Alejandro Morales-Ortega, Ana Isabel Farfán-Sedano, et al.
Rheumatology and Therapy|June 18, 2022
Letter to the Editor Regarding Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in MindDavid Bernal-Bello, David Serantes-Gómez, Aida Izquierdo-Martínez, et al.
Journal of Clinical Medicine|September 13, 2025
Cancer Risk in Autoimmune and Immune-Mediated Diseases: A Narrative Review for Practising CliniciansDavid Bernal-Bello, Begoña Frutos-Pérez, Miguel Ángel Duarte-Millán, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|December 5, 2025
Isolated pancreatic tuberculosis: A treatable diagnostic challengeDavid Bernal-Bello, David Serantes-Gómez, Álvaro Ricardo Llerena-Riofrío, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2017
Understanding the Role of Antibodies as Markers of Cancer-Associated Systemic Sclerosis: Comment on the Article by Shah et alDavid Bernal-Bello, Alfredo Guillén-Del Castillo, Albert Selva-O'Callaghan, et al.
Cancer|March 15, 2021
COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitorsAlejandro Morales-Ortega, Jaime García de Tena, Begoña Frutos-Pérez, et al.
Autoimmunity Reviews|March 13, 2017
Novel risk factors related to cancer in sclerodermaDavid Bernal-Bello, Jaime García de Tena, Alfredo Guillén-Del Castillo, et al.
Autoimmunity Reviews|May 8, 2020
Imatinib might constitute a treatment option for lung involvement in COVID-19David Bernal-Bello, Beatriz Jaenes-Barrios, Alejandro Morales-Ortega, et al.
Clinical Immunology (Orlando, Fla.)|June 30, 2020
Imatinib for COVID-19: A case reportAlejandro Morales-Ortega, David Bernal-Bello, Cristina Llarena-Barroso, et al.
The Journal of Infection|August 26, 2021
Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patientsAlejandro Morales-Ortega, Ana Isabel Farfán-Sedano, Aida Izquierdo-Martínez, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
The Lancet. Respiratory Medicine|June 20, 2021
Imatinib in COVID-19: hope and cautionDavid Bernal-Bello, Alejandro Morales-Ortega, Ana Isabel Farfán-Sedano, et al.
Rheumatology and Therapy|June 18, 2022
Letter to the Editor Regarding Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in MindDavid Bernal-Bello, David Serantes-Gómez, Aida Izquierdo-Martínez, et al.
Journal of Clinical Medicine|September 13, 2025
Cancer Risk in Autoimmune and Immune-Mediated Diseases: A Narrative Review for Practising CliniciansDavid Bernal-Bello, Begoña Frutos-Pérez, Miguel Ángel Duarte-Millán, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|December 5, 2025
Isolated pancreatic tuberculosis: A treatable diagnostic challengeDavid Bernal-Bello, David Serantes-Gómez, Álvaro Ricardo Llerena-Riofrío, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2017
Understanding the Role of Antibodies as Markers of Cancer-Associated Systemic Sclerosis: Comment on the Article by Shah et alDavid Bernal-Bello, Alfredo Guillén-Del Castillo, Albert Selva-O'Callaghan, et al.
Cancer|March 15, 2021
COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitorsAlejandro Morales-Ortega, Jaime García de Tena, Begoña Frutos-Pérez, et al.
Autoimmunity Reviews|March 13, 2017
Novel risk factors related to cancer in sclerodermaDavid Bernal-Bello, Jaime García de Tena, Alfredo Guillén-Del Castillo, et al.
Autoimmunity Reviews|May 8, 2020
Imatinib might constitute a treatment option for lung involvement in COVID-19David Bernal-Bello, Beatriz Jaenes-Barrios, Alejandro Morales-Ortega, et al.
Clinical Immunology (Orlando, Fla.)|June 30, 2020
Imatinib for COVID-19: A case reportAlejandro Morales-Ortega, David Bernal-Bello, Cristina Llarena-Barroso, et al.
The Journal of Infection|August 26, 2021
Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patientsAlejandro Morales-Ortega, Ana Isabel Farfán-Sedano, Aida Izquierdo-Martínez, et al.
Pageof 4